Company: ABUS
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012305
Chunk: 63

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 63
---
 worldwide exclusive and sublicensable license to any intellectual property that is owned or licensed by Genevant for use by us in the field of HBV. |

| 5. | Roivant agreed to contribute $37.5 million in transaction-related seed capital for Genevant, consisting of an initial $22.5 million investment and a subsequent investment of $15 million at a pre-determined, stepped-up valuation. |

On July 31, 2020, Roivant recapitalized Genevant through an equity investment and conversion of previously issued convertible debt securities held by Roivant. We participated in the recapitalization of Genevant with an equity investment of $2.5 million. In connection with the recapitalization, the three parties entered into an Amended and Restated Shareholders Agreement that provides Roivant with substantial control of Genevant. We have a non-voting observer seat on Genevant’s Board of Directors. As of March 24, 2025, we owned approximately 16% of the outstanding common shares of Genevant.

41

TABLE OF CONTENTS

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Fees Paid to Independent Registered Public Accounting Firm The following table sets forth all fees paid or accrued by us for professional services rendered by EY during the years ended December 31, 2024 and 2023:

|                    |     |     2024 |     |     2023 |
| Audit Fees(1)      |     | $700,000 |     | $684,900 |
| Audit-Related Fees |     |        — |     |        — |
| Tax Fees           |     |        — |     |        — |
| All Other Fees(2)  |     |   $3,600 |     |   $3,600 |
| Total              |     | $703,600 |     | $688,500 |

| (1) | Annual audit, quarterly reviews, internal controls, consents, comfort letters, and review of prospectus. |

| (2) | Subscription fee for use of EY’s accounting research tool. |

Audit Committee Pre-Approval Policies and Procedures Our Audit Committee charter provides that our Audit Committee will pre-approve all audit services and non-audit services to be provided by our independent registered public accounting firm before it is engaged to render these services. The Audit Committee may consult with management in the decision-making process but may not delegate this authority to management. The Audit Committee may delegate, and has in the past delegated,